New Humidification System Provides Improved Respiratory Support
By HospiMedica International staff writers Posted on 15 Sep 2016 |
Image: The F&P 950 humidification system (Photo courtesy of Fisher & Paykel Healthcare).
A high performance humidification system minimizes condensation and helps provide optimal breathing for patients.
The Fisher & Paykel Healthcare (F&P; Auckland, New Zealand) F&P 950 humidification system is designed to provide respiratory support across the care continuum of invasive, non-invasive, and Optiflow nasal high flow therapies, with a breathing circuit that remains closed and free of clinician intervention. The system consists of a heated humidifier base and an auto-fill chamber, with a touch screen intuitive user interface, integrated probes with novel sensing technologies, the breathing circuit itself, and a consumable sets.
The breathing circuit incorporates patented Evaqua technology, which minimizes mobile condensation in the expiratory limb by allowing water vapor to diffuse through the tubing wall before it can condense into liquid water within the circuit limb or within the ventilator. The result is an easy-to-use system that delivers optimal humidity (37° C, 44mg/L) to the breathing circuits, which use spiral wire technology for consistent compliance and low resistance in order to inimize the work of breathing.
“The F&P 950 system is the result of many years’ development work and we are pleased to be introducing this revolutionary new product to the market,” said Lewis Gradon, managing director and CEO of F&P Healthcare. “It is an outstanding addition to our range of products and we expect to see positive uptake in hospitals around the world.”
Active respiratory gas humidification ensures that patients on mechanical ventilation are supplied with optimally conditioned gases, with a minimal water content of 33 mg/dm³ and a maximum respiratory gas temperature of about 42° C. Adding water to respiratory gas is intended to minimize pulmonary infections and lung tissue damage, which is particularly problematic in patient populations with highly sensitive respiratory tracts (such as asthmatics), or among those requiring ventilation for longer periods of time.
Related Links:
Fisher & Paykel Healthcare
The Fisher & Paykel Healthcare (F&P; Auckland, New Zealand) F&P 950 humidification system is designed to provide respiratory support across the care continuum of invasive, non-invasive, and Optiflow nasal high flow therapies, with a breathing circuit that remains closed and free of clinician intervention. The system consists of a heated humidifier base and an auto-fill chamber, with a touch screen intuitive user interface, integrated probes with novel sensing technologies, the breathing circuit itself, and a consumable sets.
The breathing circuit incorporates patented Evaqua technology, which minimizes mobile condensation in the expiratory limb by allowing water vapor to diffuse through the tubing wall before it can condense into liquid water within the circuit limb or within the ventilator. The result is an easy-to-use system that delivers optimal humidity (37° C, 44mg/L) to the breathing circuits, which use spiral wire technology for consistent compliance and low resistance in order to inimize the work of breathing.
“The F&P 950 system is the result of many years’ development work and we are pleased to be introducing this revolutionary new product to the market,” said Lewis Gradon, managing director and CEO of F&P Healthcare. “It is an outstanding addition to our range of products and we expect to see positive uptake in hospitals around the world.”
Active respiratory gas humidification ensures that patients on mechanical ventilation are supplied with optimally conditioned gases, with a minimal water content of 33 mg/dm³ and a maximum respiratory gas temperature of about 42° C. Adding water to respiratory gas is intended to minimize pulmonary infections and lung tissue damage, which is particularly problematic in patient populations with highly sensitive respiratory tracts (such as asthmatics), or among those requiring ventilation for longer periods of time.
Related Links:
Fisher & Paykel Healthcare
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration